Grup de Recerca:
Biologia Computacional i Disseny de Fàrmacs
Informació de contacte
Departament de Farmàcia i Tecnologia Farmacèutica, i Fisicoquímica
Departament Fisicoquímica, Facultat de Farmàcia de la Universitat de Barcelona, Av. Joan XXIII s/n 934035986 jordi.juarez(a)ub.edu
Formació acadèmica
Llicenciat en Fàrmacia
Doctorado en Biomedicina
Master en Biomedicina
Projectes
Biologia Computacional i Disseny de Fàrmacs
.
2017 - 2021
. Ref.2017SGR1746
. Agència de Gestió d'Ajuts Universitaris i de Recerca (AGAUR)
. IP: Francisco Javier Luque GarrigaBases Moleculares de Cooperatividad Química en complejos ternarios de interés terápeutico
.
2021 - 2024
. Ref.PID2020-115683GA-I00
. Ministerio de Ciencia, Innovación y Universidades
. IP: Jordi Juarez JimenezIdentification of allosteric effectors causing depletion of pathology-related proteins
.
2021 - 2021
. Ref.311260
. GT Gain Therapeutics SA
. IP: Xavier Barril Alonso; Jordi Juarez Jimenez
Publicacions rellevants
Kuzmanic, A.; Bowman, G.R.; Juárez-Jiménez, J.; Michel, J.; Gervasio, F.L. Investigating Cryptic Binding Sites by Molecular Dynamics Simulations.
En
Accounts of Chemical Research.
Volum 53.
Número 3.
2020
. https://doi.org/10.1021/acs.accounts.9b00613Juárez-Jiménez, J.; Gupta, A.A; Karunanithy, G.; Mey, A.S.J.S.; Georgiou, C.; Ioannidis, H.; De Simone, A.; Barlow, P. N.; Hulme, A. N.; Walkinshaw, M.D.; Baldwin, A.J.; Michel, J. Dynamic design: manipulation of millisecond timescale motions on the energy landscape of cyclophilin A.
En
Chemical Science.
Volum 11.
2020
. Repositori InstitucionalLlabrés, S.; Juárez-Jiménez, J.; Masetti, M.; Leiva, R.; Vázquez, S.; Gazzarrini, S.; Moroni, A.; Cavalli, A.; Luque, F. J. Mechanism of the pseudo-irreversible binding of amantadine to the M2 proton channel.
En
Journal of the American Chemical Society.
Volum 138.
2016
. https://doi.org/10.1021/jacs.6b07096Juárez-Jiménez, J.; Barril, X.; Orozco, M.; Pouplana, R.; Luque, F. J. Assessing the Suitability of the Multilevel Strategy for the Conformational Analysis of Small Ligands.
En
Journal of Physical Chemistry B.
Volum 119.
Número 3.
2015
. https://doi.org/10.1021/jp506779yJuárez-Jiménez, J.; Gupta, A.A; Karunanithy, G.; Mey, A.S.J.S.; Georgiou, C.; Ioannidis, H.; De Simone, A.; Barlow, P. N.; Hulme, A. N.; Walkinshaw, M.D.; Baldwin, A.J.; Michel, J. A computationally designed binding mode flip leads to a novel class of potent tri-vector cyclophilin inhibitors.
En
Chemical Science.
Volum 10.
2018
. Repositori InstitucionalCodony, S.; Pont, C.; Griñán-Ferré, C.; Di Pede-Mattatelli, A.; Calvó-Tusell, C.; Feixas, F.; Osuna, S.; Jarné-Ferrer, J.; Naldi, M.; Bartolini, M.; Loza, M. I.; Brea, J.; Pérez, B.; Bartra, C.; Sanfeliu, C.; Juárez-Jiménez, J.; Morisseau, C.; Hammock, B. D.; Pallàs, M.; Vázquez, S.; Muñoz-Torrero, D. Discovery and in vivo proof of concept of a highly potent dual inhibitor of soluble epoxide hydrolase and acetylcholinesterase for the treatment of Alzheimer's disease.
En
Journal of Medicinal Chemistry.
Volum 65.
Número 6.
2022
. Repositori InstitucionalJuárez-Jiménez, J.; Tew, P.; O′Connor, M.; Llabrés, S.; Sage, R.; Glowacki, D.; Michel, J. Combining Virtual Reality Visualization with Ensemble Molecular Dynamics to Study Complex Protein Conformational Changes.
En
Journal of Chemical Information and Modeling.
Volum 60.
Número 12.
2020
. https://doi.org/10.1021/acs.jcim.0c00221Scott, J I; Mendive-Tapia, L; Gordon, D; Barth, N D; Thompson, E J; Cheng, Z; Taggart, D; Kitamura, T; Bravo-Blas, A; Roberts, E W; Juarez-Jimenez, J; Michel, J; Piet, B; de Vries, I J; Verdoes, M; Dawson, J; Carragher, N O; O' Connor, R A; Akram, A R; Frame, M; Serrels, A; Vendrell, M. A fluorogenic probe for granzyme B enables in-biopsy evaluation and screening of response to anticancer immunotherapies.
En
Nature Communications.
Volum 13.
Número 2366.
2022
. https://doi.org/10.1038/s41467-022-29691-w